On January 14, 2019, the European Food Safety Agency (EFSA) issued a message to set import limits for spiromesifen in coffee beans.
In accordance with Article 6 of EC No 396/2005, Bayer CropScience submitted an application to the Greek national authorities for the establishment of import limits for spironolactone in coffee beans. The application is then transferred to the European Food Safety Agency. After assessment, the European Food Safety Agency concluded that, according to the reported agricultural practices, short-term and long-term ingestion of residues from the use of spironolactone is unlikely to present a risk to consumers'health.
Some of the original reports are as follows:
In accordance with Article 6 of Regulation （EC） No 396/2005, the applicant Bayer CropScience submitted a request to the competent national authority in Greece to set an import tolerance for the active substance spiromesifen in coffee beans. The data submitted in support of the request were found to be sufficient to derive a maximum residue level （MRL） proposal for coffee beans. Adequate analytical methods for enforcement are available to control the residues of spiromesifen and spiromesifen‐enol （M01） on the commodity under consideration at the validated limit of quantification （LOQ） of 0.01 mg/kg for each compound. based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the use of spiromesifen according to the reported agricultural practices is unlikely to present a risk to consumer health.
